Moreover, recent reports have also shown that the elevated levels of anti-AnxA2 antibodies are observed among COVID-19 patients causing cytokine storm that may finally lead to systemic thrombosis, cell death, and non-cardiogenic pulmonary oedema [42,92,93]. The gene discussed is ANXA2; the disease is COVID-19.